| Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma J Iqbal, G Wright, C Wang, A Rosenwald, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 123 (19), 2915-2923, 2014 | 518 | 2014 |
| SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group YL Kwong, WS Kim, ST Lim, SJ Kim, T Tang, E Tse, AYH Leung, CS Chim Blood, The Journal of the American Society of Hematology 120 (15), 2973-2980, 2012 | 450 | 2012 |
| A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis SJ Kim, DH Yoon, A Jaccard, WJ Chng, ST Lim, H Hong, Y Park, ... The lancet oncology 17 (3), 389-400, 2016 | 354 | 2016 |
| Janus kinase 3–activating mutations identified in natural killer/T-cell Lymphoma GC Koo, SY Tan, T Tang, SL Poon, GE Allen, L Tan, SC Chong, WS Ong, ... Cancer discovery 2 (7), 591-597, 2012 | 289 | 2012 |
| Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma TL Song, ML Nairismägi, Y Laurensia, JQ Lim, J Tan, ZM Li, WL Pang, ... Blood, The Journal of the American Society of Hematology 132 (11), 1146-1158, 2018 | 287 | 2018 |
| AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre–highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival … ST Lim, R Karim, BN Nathwani, A Tulpule, B Espina, AM Levine Journal of Clinical Oncology 23 (19), 4430-4438, 2005 | 237 | 2005 |
| Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma TB Heavican, A Bouska, J Yu, W Lone, C Amador, Q Gong, W Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 133 (15), 1664-1676, 2019 | 227 | 2019 |
| Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma CC Khor, T Do, H Jia, M Nakano, R George, K Abu-Amero, R Duvesh, ... Nature genetics 48 (5), 556-562, 2016 | 185 | 2016 |
| Recurrence after successful percutaneous endoscopic lumbar discectomy JM Kim, SH Lee, Y Ahn, DH Yoon, CD Lee, ST Lim min-Minimally Invasive Neurosurgery 50 (02), 82-85, 2007 | 185 | 2007 |
| High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma JYY Ngeow, RHH Quek, DCE Ng, SW Hee, M Tao, LC Lim, YH Tan, ... Annals of oncology 20 (9), 1543-1547, 2009 | 178 | 2009 |
| Type II enteropathy‐associated T‐cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group E Tse, H Gill, F Loong, SJ Kim, SB Ng, T Tang, YH Ko, WJ Chng, ST Lim, ... American journal of hematology 87 (7), 663-668, 2012 | 171 | 2012 |
| Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ... The Journal of clinical investigation 126 (1), 68-84, 2016 | 165 | 2016 |
| Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre-and post-rituximab WM Tai, J Chung, PL Tang, YX Koo, X Hou, KW Tay, R Quek, M Tao, ... Annals of hematology 90, 809-818, 2011 | 164 | 2011 |
| Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy ST Lim, R Karim, A Tulpule, BN Nathwani, AM Levine Journal of Clinical Oncology 23 (33), 8477-8482, 2005 | 152 | 2005 |
| Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group SJ Kim, C Hsu, YQ Song, K Tay, XN Hong, J Cao, JS Kim, HS Eom, ... European journal of cancer 49 (16), 3486-3496, 2013 | 149 | 2013 |
| Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009 YL Kwong, BO Anderson, R Advani, WS Kim, AM Levine, ST Lim The lancet oncology 10 (11), 1093-1101, 2009 | 149 | 2009 |
| Simultaneous inhibition of PI3Kδ and PI3Kα induces ABC-DLBCL regression by blocking BCR-dependent and-independent activation of NF-κB and AKT J Paul, M Soujon, AM Wengner, S Zitzmann-Kolbe, A Sturz, K Haike, ... Cancer cell 31 (1), 64-78, 2017 | 145 | 2017 |
| JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma ML Nairismägi, J Tan, JQ Lim, S Nagarajan, CCY Ng, V Rajasegaran, ... Leukemia 30 (6), 1311-1319, 2016 | 142 | 2016 |
| Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry C Amador, TC Greiner, TB Heavican, LM Smith, KT Galvis, W Lone, ... Blood, The Journal of the American Society of Hematology 134 (24), 2159-2170, 2019 | 136 | 2019 |
| Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype SY Tan, SS Chuang, T Tang, L Tan, YH Ko, KL Chuah, SB Ng, WJ Chng, ... Leukemia 27 (8), 1688-1696, 2013 | 128 | 2013 |
